Pseudomonas aeruginosa is an important Gram-negative opportunistic pathogen which
causes many severe acute and chronic infections with high morbidity, and mortality rates as …

The emergence of antibiotic resistant bacteria in the healthcare is a serious concern. In the
Healthcare premises precisely intensive care unit are major sources of microbial diversity …

The emergence of multidrug-resistant Gram-negative bacteria that cause nosocomial
infections is a growing problem worldwide. Colistin was first introduced in 1952 and was …

Bacterial biofilms present a significant medical challenge because they are recalcitrant to
current therapeutic regimes. A key component of biofilm formation in the opportunistic …

Infections caused by drug-resistant bacteria, particularly Gram-negative organisms, are
increasingly difficult to treat using antibiotics. A potential alternative is “phage therapy”, in …

In relation to emerging multiresistant bacteria, development of antimicrobials and new
treatment strategies of infections should be expected to become a high-priority research …

Increasing multidrug resistance in Gram-negative bacteria, in particular Pseudomonas
aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, presents a critical …

Background Novel methods are necessary to reduce morbidity and mortality of patients
suffering from infections with Pseudomonas aeruginosa. Being the most common infectious …

Pseudomonas aeruginosa is a major cause of nosocomial infections. This organism shows
a remarkable capacity to resist antibiotics, either intrinsically (because of constitutive …

The rapid emergence of antimicrobial resistance (AMR) pathogens highlights the urgent
need to approach this global burden with alternative strategies. Cefiderocol (Fetroja®) is a …